N-alkylated cyclic peptide melanocortin agonists
US8247530B2 · kind B2 · utility
4Cited by
13References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2006 |
| Grant date | Aug 21, 2012 |
| Priority date | — |
| Expiry date | Jun 22, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A melanocortin-4 receptor agonist cyclic peptide of the formulawhere R1, R2, R3, R4a, R4b, R5, R6, R7a, R7b, x, y and z are as defined in the specification, and a method of treating sexual dysfunction, including male erectile dysfunction and female sexual dysfunction, and other melanocortin 4 receptor responsive conditions and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.